| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |